---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-008129"
form_type: "8-K"
ticker: "CRBP"
cik: "0001595097"
company_name: "Corbus Pharmaceuticals Holdings, Inc."
filed_at: "2024-01-29T23:59:59+00:00"
generated_at: "2026-06-06T15:56:34.969583+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Corbus reports preliminary cash of $20.9M as of Dec 31, 2023; raised $16.8M via ATM

## Summary
- Raised approximately $16.8M in gross proceeds from common stock sales under Open Market Sale Agreement with Jefferies.
- Preliminary cash, cash equivalents, and investments of ~$20.9M as of Dec 31, 2023, including $13.7M in cash.
- Financial statements for year ended Dec 31, 2023 not yet finalized; amounts subject to adjustments.
- Company has not provided any revenue or earnings guidance in this update.

## SEC filing metadata
- accession: 0000950170-24-008129
- form_type: 8-K
- ticker: CRBP
- cik: 0001595097
- company_name: Corbus Pharmaceuticals Holdings, Inc.
- filed_at: 2024-01-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1595097/000095017024008129/0000950170-24-008129-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1595097/000095017024008129/crbp-20240129.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-008129
- JSON: https://secwatch.observer/filing/0000950170-24-008129.json
- Plain text: https://secwatch.observer/filing/0000950170-24-008129.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.